Fundraising Fox
Orphalan
Paris, FR · 146 employees on LinkedIn · 2 known investors
Find your way into Orphalan
Sign up to see every warm intro you have to Orphalan
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orphalan team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orphalan develops and commercializes innovative therapies for patients with rare diseases, with a focus on unmet medical needs where current treatments are limited or absent. The company has successfully brought trientine tetrahydrochloride (Cuprior®/Cuvrior®) to market for Wilson disease treatment across 30+ countries.
Founders & leadership
DP
Dmitry ParamonovDmitry Paramonov has 24 years of experience in healthcare across startups and large organizations, including 20 years in the medical device and pharmaceutical industries at Fortune 100 companies and 4 years in management consulting at AT Kearney; he holds an MBA from Kellogg and is fluent in four languages.
JF
John Fatuhi
AB
Angelita BriffaAngelita Briffa is a finance executive who has held CFO roles at both startup and publicly listed companies, with experience building finance teams and implementing operational improvements to support strategic business objectives.
OC
Omar Camille Kamlin
NZ
Nabeel ZubairNabeel Zubair is a product and technology executive with over 20 years of experience in healthtech, fintech, and telecom, including roles at Jazz and King's College Hospital. He has built and scaled multiple SaaS ventures and led digital transformation initiatives incorporating AI and data analytics.
MP
Margot Pisani
SK
Sujatha Karoor
IS
Ivo SulovskyIvo Sulovsky is an executive in the biotechnology industry with expertise in pharmaceutics, business development, and general management. He holds an MSc in Commerce/Business Administration from Wirtschaftsuniversität Wien and leads Orphalan, which develops therapies for rare diseases including Wilson disease treatments.
Board
NA
Naseem Amin
Investors · 2
In the news
Frequently asked questions
- What does Orphalan do?
- Orphalan develops and commercializes innovative therapies for patients with rare diseases, with a focus on unmet medical needs where current treatments are limited or absent. The company has successfully brought trientine tetrahydrochloride (Cuprior®/Cuvrior®) to market for Wilson disease treatment across 30+ countries.
- Who are Orphalan's investors?
- Orphalan's investors include Advent Life Sciences, Bpifrance.
- Where is Orphalan headquartered?
- Orphalan is headquartered in Paris, FR.